Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
DAWN
DAWN News & Events
-
Add to Watchlist
Trade DAWN
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
DAWN News
DAY ONE BIOPHARMACEUTICALS ANTICIPATES TOPLINE RESULTS FROM FIREFLY-2 CLINICAL TRIAL BY MID-2027
3d ago
moomoo
DAY ONE AND SERVIER FINISH ENROLLMENT IN KEY PHASE 3 FIREFLY-2 TRIAL OF TOVORAFENIB FOR FRONT-LINE TREATMENT OF PEDIATRIC LOW-GRADE GLIOMA (PLGG)
3d ago
moomoo
Servier Completes Acquisition of Day One Biopharmaceuticals
Apr 23 2026
PRnewswire
Servier Completes Acquisition of Day One Biopharmaceuticals
Apr 23 2026
PRnewswire
Servier Completes Acquisition of Day One Biopharmaceuticals
Apr 23 2026
PRnewswire
Investor Rights Law Firm Investigates Multiple Companies
Apr 09 2026
PRnewswire
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
Mar 27 2026
PRnewswire
M&A Deal Closures Present Opportunities: Target Janus Henderson and Other Stocks.
Mar 25 2026
Barron's
Show More News
DAWN Events
No data
DAWN Monitor News
Servier Acquires Day One Biopharmaceuticals for $2.5 Billion
Mar 06 2026
Day One Biopharmaceuticals Surges Amid Takeover Rumors
Mar 04 2026
Day One Biopharmaceuticals Reports Strong Revenue Growth and Acquisition
Jan 12 2026
DAWN Earnings Analysis
No Data
People Also Watch
